Literature DB >> 3946215

Exercise ventilation and pulmonary artery wedge pressure in chronic stable congestive heart failure.

L I Fink, J R Wilson, N Ferraro.   

Abstract

In patients with chronic heart failure (CHF), physical exertion frequently is associated with higher than normal ventilatory levels and dyspnea. To determine the prevalence of such excessive ventilatory responses in CHF and whether this excessive ventilation is a result of acute increases in intrapulmonary pressure during exercise, minute ventilation (VE) and pulmonary artery (PA) wedge pressure were measured during maximal bicycle exercise in 38 patients with chronic CHF. It was then determined whether reducing the PA wedge pressure during exercise with prazosin (9 patients) or dobutamine (6 patients) reduced ventilatory levels toward normal. To compare ventilation between patients, VE was correlated with minute carbon dioxide production (VCO2) (r greater than or equal to 0.90); the calculated VE at a VCO2 of 1 liter/min (VE-CO2) was derived from this relation and used as a normalized index of ventilation. During exercise, VE-CO2 ranged from 27 to 71 liters/min, exceeding the normal range in 37 of 38 patients (normal 33 liters/min or less). VE-CO2 did not correlate with peak exercise PA wedge pressure and correlated only weakly with PA wedge pressure at rest (r = 0.48). Acute reduction in the PA wedge pressure during exercise with prazosin or dobutamine did not significantly reduce VE-CO2. These data suggest that ventilatory levels are frequently excessive during exercise in patients with CHF and therefore may provide a useful, objective index of their altered pulmonary function. In addition, our data suggest that this excessive ventilation is not a result of acute changes in intrapulmonary pressure during exercise.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3946215     DOI: 10.1016/0002-9149(86)90900-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  25 in total

Review 1.  Origin of symptoms in chronic heart failure.

Authors:  A L Clark
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

Review 2.  Exercise and heart failure: assessment and treatment.

Authors:  Andrew L Clark
Journal:  Heart       Date:  2006-05       Impact factor: 5.994

Review 3.  Exercise intolerance.

Authors:  Dalane W Kitzman; Leanne Groban
Journal:  Heart Fail Clin       Date:  2008-01       Impact factor: 3.179

4.  Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes.

Authors:  G Vescovo; M Volterrani; R Zennaro; M Sandri; C Ceconi; R Lorusso; R Ferrari; G B Ambrosio; L Dalla Libera
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

5.  Endothelial control of lower limb blood flow in chronic heart failure.

Authors:  D C Lindsay; D R Holdright; D Clarke; I S Anand; P A Poole-Wilson; P Collins
Journal:  Heart       Date:  1996-05       Impact factor: 5.994

6.  Relationship between exercise hyperpnea, hemodynamics, and blood gases before and during glyceryl trinitrate infusion in patients with exercise-induced elevation of pulmonary artery wedge pressure.

Authors:  L H Jørgensen; E Thaulow; H E Refsum
Journal:  Clin Cardiol       Date:  1997-09       Impact factor: 2.882

7.  Skeletal muscle metabolism during exercise in patients with chronic heart failure.

Authors:  M Schaufelberger; B O Eriksson; P Held; K Swedberg
Journal:  Heart       Date:  1996-07       Impact factor: 5.994

Review 8.  Exercise and heart transplantation. A review.

Authors:  G Niset; L Hermans; P Depelchin
Journal:  Sports Med       Date:  1991-12       Impact factor: 11.136

9.  Syndrome X and hyperventilation.

Authors:  N P Lewis; S J Hutchison; N Willis; A H Henderson
Journal:  Br Heart J       Date:  1991-02

10.  Reduction of mismatch of global ventilation and perfusion on exercise is related to exercise capacity in chronic heart failure.

Authors:  N G Uren; S W Davies; J E Agnew; A G Irwin; S L Jordan; A J Hilson; D P Lipkin
Journal:  Br Heart J       Date:  1993-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.